Background
==========

Since first described by Cairns in 1968 \[[@B1]\], trabeculectomy (TE) has been widely used and remains the gold standard in surgical treatment of glaucoma. Long-term success depends on preoperative and intraoperative conditions, but long-term success also highly depends on the persistence of filtration efficiency at the bleb site. Therefore, postoperative observation and care of the developing filtering bleb in clinical practice is an important tool in reaching the target pressure after filtration surgery in a higher percentage of the patients \[[@B2],[@B3]\].

Since 1989, a number of observations and classifications of filtering blebs using morphological criteria have been described \[[@B4]-[@B7]\]. These early efforts included various assessments of filtering bleb morphology and emphasize a general consensus in the morphologic features that indicate favourable in contrast to unfavourable filtering bleb development \[[@B8]\]. The most frequent matter of failing filtering surgery is still subconjunctival scarring which needs intensified postoperative care of the filtering bleb even if intraocular pressure (IOP) remains well controlled \[[@B9]\]. In order to allow a well-structured assessment of bleb morphology and to predict potential signs of failure early enough (to initiate wound healing modulation therapy), different bleb grading systems including the classification system described by Picht and Grehn \[[@B10],[@B11]\], the Indiana Bleb Appearance Grading Scale (IBAGS) \[[@B8]\] and the Moorfileds Bleb Grading System (MBGS) \[[@B12]\] were published. All of them have been developed as stand-alone grading tools. The 'Wuerzburg bleb classification score (WBCS)', based on the bleb classification as described by Picht and Grehn \[[@B10],[@B11]\] was the first standardized grading system and was introduced in a prospective study to investigate the influence of clear cornea phacoemulsification on filtering bleb morphology, function and IOP \[[@B13]\]. The WBCS and its modification is often used as well in recently announced studies \[[@B14]-[@B17]\] as in clinical practice and consistent evaluation and documentation is given by satisfactory interobserver variability \[[@B18]\]. The careful clinical bleb evaluation following the WBCS includes the items vascularisation, corkscrew vessels, encapsulation and microcysts. The item height is usually excluded from the score as it may have favourable and unfavourable aspects as the filtering bleb can be prominent either in over filtering or in encapsulated blebs \[[@B2]\]. In a semi quantitative analysis in 1998, Picht and Grehn found out that filtering blebs with favourable outcomes had a higher quantity of microcysts, a lower quantity of conjunctival and corkscrew vessels, a lower prevalence of encapsulation, and a decrease in height compared to filtering blebs with unfavourable outcome \[[@B11]\]. In agreement, Sacu *et al.*\[[@B19]\] demonstrated 2003 that filtering blebs with conjunctival subepithelial microcysts showed a good prognosis whereas corkscrew vessels are associated with a higher risk of encapsulation. Nevertheless, the control of IOP remains the principal goal of all current glaucoma treatment to avoid progression of optic nerve damage \[[@B20]-[@B22]\], and therefore the main aim of this study was to analyse the agreement between the morphological appearance of the filtering bleb using the WBCS and the IOP. Furthermore, we looked for agreements between single items of the WBCS and the IOP and we analysed the interobserver variability of the WBCS. In this first study we wanted to evaluate the usability and overall correlation of the WBCS and IOP in clinical practice.

Methods
=======

In this prospective study, we analyzed 57 eyes of 51 consecutive patients who had undergone primary fornix-based TE with intraoperative Mitomycin C (MMC, 0.25mg/ml) between February 2007 and September 2009 by one experienced glaucoma specialist (JF). The application time of MMC varied between 2.5 minutes and 3.5 minutes. Diagnoses were as follows: Primary open-angle glaucoma (42%), pseudoexfoliative glaucoma (42%), normal pressure glaucoma (7%), chronic angle-closure glaucoma (3.5%), juvenile glaucoma (3.5%) and dysgenetic changes in the chamber angle (2%). The study was performed at the UniversityHospital Zurich, Switzerland and was approved by the local Ethics committee. It was conducted adhering to the tenets of the Helsinki Declaration and in compliance with all local and national regulations and directives. After trabeculectomy all patients of the defined study period were invited to participate in this prospective study. Signed informed consent was obtained prior to first study related examination.

All study patients were examined once after trabeculectomy between April 2009 and March 2010. The study Data recorded were gender, age at the time of TE, eye, glaucoma diagnosis and postoperative secondary interventions. In addition, use of anti-hypertensive medication was noted. Ophthalmic examinations were performed between 16 and 1007 days after operation (mean 536 ± 226 days) by one examiner (SF) and consisted of IOP, best corrected visual acuity and slit lamp biomicroscopy. The IOP was measured with Goldmann applanation tonometry \[[@B23]\]. The tonometer (AT 900, Haag-Streit AG, Könitz, Switzerland) was calibrated by the manufacturer periodically. At the same visit, slit-lamp photographs were obtained of every filtering bleb in order to enable subsequent masked grading of morphological bleb appearance by two examiners (JF and MT-H), with differing levels of clinical experience. Bleb photography included an overview in a standardized fashion as well as slit-lamp perspective through the area of maximal bleb elevation at an angle of 45 degrees (Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}). The detailed grading and scoring of the photographs was conducted following the WBCS criteria, which includes the items vascularisation, corkscrew vessels, encapsulation and microcysts (Table [1](#T1){ref-type="table"}). Most parameters are scored from 0 to 3. The height of the bleb was noted separately using multiples of corneal thickness. It is based on the highest point from the scleral surface to the bleb. The WBCS is considered to be used in daily clinical practice by ophthalmologists with different levels of experience. The filtering bleb pictures were evaluated by the two raters. One was well trained the other had less experience. It was not possible to grade the microcysts on the photographs in most cases. The presence or absence of microcysts was evaluated and graded at the same time as the clinical examination by the glaucoma specialist (JF) using the slit-lamp, as it is not possible to grade microcysts in every part of the filtering bleb solely from photographs. They were scored per third of the bleb area containing microcysts.

![**(a) overview, (b) slitlamp photograph: Filtering bleb with WBCS = 11 points (Vascularisation = 2, Corkscrew vessels = 3, Encapsulation = 3, Microcysts = 3).** IOP postoperatively = 13 mmHg, no anticlaucoma medication, no additional secondary intervention. a) overview b) slit lamp photograph.](1471-2415-12-24-1){#F1}

![**(a) overview, (b) slitlamp photograph: Filtering bleb with WBCS = 6 points (Vascularisation = 2, Corkscrew vessels = 3, Encapsulation = 1, Microcysts = 0).** IOP postoperatively = 18 mmHg, no antiglaucoma medication, 1 additional secondary intervention (cyclophotocoagulation). a) overview b) slit lamp photograph.](1471-2415-12-24-2){#F2}

###### 

WBCS

  **Parameters**                        **Scoring**
  ------------------------------------- -----------------
  Vascularity                           3 = avascular
  2 = similar to adjacent conjunctiva   
  1 = increased                         
  0 = massive                           
  Corkscrew vessels                     3 = none
  2 = in one third                      
  1 = in two thirds                     
  0 = entire bleb                       
  Encapsulation                         3 = none
  2 = in one third                      
  1 = in two thirds                     
  0 = entire bleb                       
  Microcysts                            3 = entire bleb
  2 = lateral or medial of the flap     
  1 = over the scleral flap             
  0 = none                              

When evaluating treatment outcomes, long-term IOP control was classified as 'successful' if IOP postoperatively did not exceed 21 mmHg and was reduced by at least 20% of the preoperative level without any antiglaucoma medication and without any additional intervention, e.g. cyclophotocoagulation and re-trabeculectomy (target IOP). The preoperative IOP level was defined as that measured at the last clinical visit prior to surgery. The filtering bleb was classified as 'successful' if the bleb attained a WBCS of at least 10 points as suggested by Klink *et al.*\[[@B13]\]. In a second approach, we noted the numbers of 'successful blebs' when defining success as attaining a WBCS of 9, 8, 7, 6 or 5 points. The WBCS scores included in the analysis where those obtained by our experienced glaucoma specialist (JF). The results of the bleb grading undertaken by the second practitioner (MT-H) were noted separately.

Statistical analysis was performed using Excel for Windows (Microsoft Office 2003, Microsoft Corp., WA, USA) and PASW statistics software (version 18.0.0, SPSS Inc. Chicago, IL, USA). In order to calculate the agreement between our two definitions of success we used cross-classified tables with к-values. For interpreting levels of agreement, the following guidelines were employed: к = 0: no agreement better than chance, к \< 0.20: poor strength of agreement, к = 0.21 - 0.40: fair strength of agreement, к = 0.41 - 0.60: moderate strength of agreement, к = 0.61 - 0.80: good strength of agreement, к = 0.81 - 1.00: very good strength of agreement.

To reflect the clinical reproducibility of the WBCS, the consistency and absolute agreement of the two graders was calculated with the intraclass correlation coefficient (ICC) using a 2-way random model. Levels of agreement that were \> 0.81 were defined as excellent agreement, levels between 0.61 and 0.80 were defined as good agreement, levels between 0.41 and 0.60 were defined as moderate agreement, levels between 0.21 and 0.40 were defined as fair agreement and levels less than 0.21 were defined as poor agreement \[[@B18],[@B24]\]. Systematic biases as well as limits of agreement were evaluated by using Bland-Altman plots in MedCalc Statistical software (version 11.3.6, MedCalc Software bvba, Mariakerke, Belgium, data not shown).

Results
=======

In 57 eyes of 51 consecutive patients (31 left eyes, 26 right eyes), a fornix-based TE with intraoperative MMC was performed. 20 patients were men and 31 were women. The mean age of the patients was 67.6 ± 11.8 years (30.2-84.1 years) on the day of surgery. Sixteen patients (16 eyes) were unable to complete all of the required follow-up examinations. In 11 patients this was due to unwillingness to attend the clinic in order to complete the examinations, three further patients lived overseas, whilst two more patients were unable to attend during the study period because of pre-existing health problems. Mean follow-up period was 536 ± 226 days (16--1007 days) post intervention. Mean number of IOP-lowering drugs decreased from 2.5 ± 1.4 preoperatively to 0.3 ± 0.8 postoperatively on the day of study visit. In 49 eyes (85.96%) IOP lowering treatment could even be stopped, while it could be at least lowered in 5 eyes (8.77%). Only three eyes (5.26%) needed the same number of antiglaucoma medicines as before. After TE the mean IOP decreased by 10.8 mmHg compared to the mean IOP prior surgery; mean IOP preoperatively was 24.0 ± 6.5 mmHg compared to 13.2 ± 7.3 mmHg postoperatively.

On the day of the ophthalmic examination, 44 (77.2%) eyes were found to achieve an IOP of less than or equal to 21 mmHg and an IOP reduction of at least 20% compared to the preoperative level, without antiglaucoma medication. 42 eyes (73.7%) reached the target pressure. Using the gradings of our experienced glaucoma specialist (JF), 25 eyes reached a WBCS score of ≥10 points (43.9%). Thus, comparing these two definitions of success, more eyes were classified as successful based on IOP (73.7%) rather than WBCS (43.9%). Further, 36 eyes attained a score of ≥9 points (63.2%), 47 eyes ≥8 points (82.5%), 48 eyes ≥7 points (84.2%) and 53 eyes both ≥6 and ≥ 5 points (93%).

Table [2](#T2){ref-type="table"} shows the agreement between target pressure and different scores of the WBCS. There is a poor agreement between target IOP and WBCS of ≥10 points (к 0.17), ≥9 points (к 0.20), ≥6 points and ≥5 points, respectively (к 0.11). Nevertheless, fair agreement was found for WBCS scoring of ≥8 points and ≥7 points (к 0.24 and 0.27, respectively). Therefore, the best agreement was found between target IOP and WBCS of at least 7 points. From the 25 eyes reaching a WBCS of ≥10 points, 21 also reached the target pressure (84%).

###### 

Cross table target pressure vs. different scores including value of agreement

                               **Score ≥ 10**   **Score ≥ 9**   **Score ≥ 8**   **Score ≥ 7**   **Score ≥ 6**   **Score ≥ 5**                              
  -------------------- ------- ---------------- --------------- --------------- --------------- --------------- --------------- ---- ----- ---- ----- ---- -----
  Target IOP reached   No      11               4               8               7               5               10              5    10    2    13    2    13
  Yes                  21      21               13              29              5               37              4               38   2     40   2     40   
  Agreement            Kappa                    .17                             .19                             .24                  .27        .11        .11

Regarding agreement between single items of the WBCS and target pressure, best agreement was found between occurrence of microcysts and target IOP reached (к 0.22 -- 0.34, Table [3](#T3){ref-type="table"}) and between extent of vascularity and target IOP not reached (к 0.31, Table [4](#T4){ref-type="table"}). The more microcysts that exist on the filtering bleb, the better is the agreement with reaching the target pressure. In contrast, we found poor strength of agreement between the IOP and the factors of cork screw vessels and encapsulation.

###### 

Cross table target pressure vs. microcysts including value of agreement

                       **Microcysts 3 points**   **Microcysts ≥ 2 points**   **Microcysts ≥ 1 point**                   
  -------------------- ------------------------- --------------------------- -------------------------- ---- ----- ---- -----
  Target IOP reached   No                        14                          1                          8    7     6    9
  Yes                  25                        17                          9                          33   4     38   
  Agreement            Kappa                                                 .22                             .31        .34

###### 

Cross table target pressure vs. vascularization including value of agreement

                           **Vascularization ≤ 1 point**        
  ------------------------ ------------------------------- ---- -----
  Target IOP not reached   No                              39   3
  Yes                      10                              5    
  Agreement                Kappa                                .31

The agreement between the WBCS and IOP using the results of the grader with less clinical experience (MTH) were as follows: poor agreement between target IOP and WBCS of ≥10 points, ≥9 points, ≥7points, ≥6 points and ≥5 points (к 0.12, 0.095, 0.149, 0.169, 0.026) and fair agreement between target IOP and WBCS of ≥8 points (к 0.219).

Table [5](#T5){ref-type="table"} shows the ICC between the two raters. Consistency and absolute agreement of the two raters were: vascularisation +0.77/+0.73, corkscrew vessels +0.73/0.72, encapsulation +0.49/+0.49, bleb height +0.87/+0.85 and bleb score without microcysts +0.63/+0.61. By using Bland-Altman plots, systemic bias could be excluded for the factors corkscrew vessels and encapsulation. Vascularization and bleb score without microcysts were scored higher by the experienced glaucoma specialist while the item bleb height was scored higher by the grader with less clinical experience.

###### 

Bleb morphology graded from photographs: consistency and absolute agreement between the two raters

                             **Consistency**   **Absolute agreement**
  -------------------------- ----------------- ------------------------
  Vascularization            0.77              0.73
  Corkscrew vessels          0.73              0.72
  Encapsulation              0.49              0.49
  Bleb height                0.87              0.85
  Score without microcysts   0.63              0.61

Limits of agreements (evaluated by Bland-Altman plots): vascularization +1.41/-0.81, corkscrew vessels +1.48/-1.17, encapsulation +2.4/-2.0, bleb height +1.21/-1.88, bleb score without microcysts +3.0/-2.6.

Discussion
==========

The main aim of our prospective study was to investigate whether there is an agreement between postoperative IOP and the WBCS. Klink *et al.* established a semi-quantitative score and classified the filtering blebs before and after clear cornea phacoemulsification as 'favourable' when they reached a WBCS of 10 points or more, and 'unfavourable' if less than 10 points were scored \[[@B13]\]. Using this classification of 'success' of bleb morphology as detectable with slit lamp biomicroscopy, we found only poor agreement to our defined target IOP (Table [2](#T2){ref-type="table"}). But after expanding the definition of 'success' on the morphological findings, we found fair agreement between the attainment of at least 7 points (к 0.273) and our target IOP (Table [2](#T2){ref-type="table"}). Based on these findings we conclude that the WBCS is applicable in clinical practice. It is very interesting to compare these results with those published by Klink *et al*. Even though they did not find any prognostic value of the early WBCS bleb score for the long-term success of TE (20% pressure reduction with reference to the pretreated IOP level and an upper IOP limit of 21 mmHg without glaucoma medication), they found that bleb score of more than 8 points in the first two weeks after TE seemed to be associated with a lower IOP (≤12 mmHg) 1 year postoperatively, while patients with a total bleb score of less than 7.0 two weeks postoperatively showed a higher IOP \[[@B25]\]. Our study compares the WBCS and a defined target IOP at the same time, but nonetheless we found a similar 'cut off' on the WBCS scale. The fact that in our study 21 out of 25 eyes reaching a WBCS of ≥ 10 points also achieved the target IOP (84%) indicates that the WBCS works well in predicting IOP control when at least ten points are attained.

In addition, we looked for agreements between single items of the WBCS and the postoperative IOP. We found a fair agreement between the occurrence of microcysts and reaching the target pressure. This is in accordance with Picht *et al.*\[[@B11],[@B16]\] and Sacu *et al.*\[[@B19]\]. In contrast, our data reveal that excessive vascularisation shows a fair agreement to higher IOP postoperatively but we found no agreement between the presence of corkscrew vessels and IOP, nor between presence of bleb encapsulation and IOP.

Our study strengthens the clinical utility of the WBCS with good interobserver consistency, and absolute agreement in assessment of the factors vascularisation, corkscrew vessels and bleb score (excluding microcysts). The item bleb height was evaluated with excellent consistency and absolute agreement. In comparison, the data of Klink *et al.* revealed that bleb height was detected with moderate consistency and absolute agreement, whereas consistency of all other parameters were good (single ICC) or excellent (average ICC) \[[@B18]\].

Morphological slit-lamp biomicroscopy grading systems like the WBCS, the IBAGS or the MBCS only allow describing the surface and the superficial layers of the bleb. Even though there exist newer methods of describing filtering blebs, for example examining the internal bleb structure using ultrasound biomicroscopy \[[@B26]\], anterior segment optical coherence tomography \[[@B14],[@B27]-[@B30]\] and in-vivo confocal microscopy \[[@B15],[@B31],[@B32]\], the WBCS remains an important tool to describe morphological appearance in clinical practice, as it is easy to use in routine practice, non-invasive and cost-efficient. Further, consistent evaluation is given by satisfactory interobserver variability as shown by Klink *et al.*\[[@B18]\] as well as by our data. Nevertheless, the new imaging methods might provide additional information and prognostic indicators. Also, as wound healing is modulated by the use of anti-TGFβ2 antibodies \[[@B33]-[@B35]\] and Mitomycin C supplemented with Cross-Linking Hyaluronic Acid \[[@B36]\] the use of WBCS and other classification systems remains necessary for a careful examination of the developing filtering bleb to recognize early bleb failure.

The main aim of filtering surgery is to achieve low levels of intraocular pressure in order to prevent further visual field loss \[[@B37]\]. Therefore, the success after TE can be measured by the achievement of a certain level of IOP. As shown in a recently-published study by Rotchford *et al.*, there exist currently 92 different IOP-based definitions of success \[[@B38]\]. For our study, we defined 'success' concerning IOP as reaching a target pressure of less or equal to 21 mmHg and IOP reduction of at least 20% of the preoperative level without any antiglaucoma medication and without any additional interventions. Using this definition of success, clinical outcomes following fornix-based TE within the last two years at our clinic were satisfying. 73.7% of our study group were classified as 'successful' and reached the target pressure defined above.

If additional interventions are excluded from our definition of success, the success rate increases to 77.2%. This result is comparable with other studies, which report similar success rates (between 73.9% and 76%) using the same definition of success \[[@B3],[@B25],[@B39]\].

We are aware that the ultimate goal of any bleb classification system is to predict the development of IOP over longer post-intervention periods. As agreement between WBCS and target IOP is a necessary precondition, this study only compares target IOP and WBCS at the same time to evaluate the usability and overall correlation of the WBCS and IOP in clinical practice. Therefore, no subgroup splitting according to time after surgery has been done and two examines with different levels of experience have been chosen. A larger study is ongoing to investigate the agreement of the WBCS score at early postoperative visit (\<3 month and at 3 month) with the WBCS score at a later timepoint (6, 12 and 24 month). In this subsequent study we want to know if the \<3 or 3 month WBCS score predicts the outcome (IOP and success) of eyes after trabeculectomy after 6, 12 and 24 month post surgery.

Conclusion
==========

To compare the agreement between the WBCS at \<3 month and at 3 month after surgery and target IOP 6, 12 and 24 month after intervention, a follow-up study is currently in progress. In conclusion, evaluating filtering blebs after trabeculectomy by using the Wuerzburg bleb classification score is a useful tool for predicting intraocular pressure control if at least 7 points are scored. The more microcysts exist on the filtering bleb, the better the agreement with reaching the target pressure.
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